Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −58,506−100.0% | Sold out | Holders |
| Q2 2023 | 58,506 | $20.6M | 0.1% | −37,394−39.0% | Reduced | Holders |
| Q1 2023 | 95,900 | $30.2M | 0.2% | −21,300−18.2% | Reduced | Holders |
| Q4 2022 | 117,200 | $33.8M | 0.2% | +4,200+3.7% | Added | Holders |
| Q3 2022 | 113,000 | $32.7M | 0.2% | −500−0.4% | Reduced | Holders |
| Q2 2022 | 113,500 | $32.0M | 0.2% | +31,400+38.2% | Added | Holders |
| Q1 2022 | 82,100 | $21.4M | 0.1% | +82,100 | New | Holders |